ArticleJournal of multidisciplinary healthcare2024
Impact of Vitamin D and IL-1β on Quality of Life in Pediatric Drug-Resistant Epilepsy.
Article in Journal of multidisciplinary healthcare, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Epilepsy is highly prevalent among children worldwide, making it one of the most common neurological disorders. Drug-Resistant Epilepsy (DRE) significantly impacts the quality of life (QoL) of affected children, attributed to factors such as seizure frequency and severity, low vitamin D levels, comorbidities, radiological abnormalities, and elevated IL-1β levels. Objective: This study aims to identify the factors most significantly affecting the QoL in children with DRE. Methods: This cross-sectional study at Adam Malik Hospital involved children with DRE. Participants' QoL was assessed with the QOLCE-55 score, while epilepsy severity was measured using the HASS score. Vitamin D status was quantified by serum 25-hydroxy vitamin D (25(OH)D) levels, and IL-1β levels were measured using the ELISA method. Multivariate logistic regression analysis using Pearson and Spearman test was conducted to evaluate risk factors that significantly impact the QoL of children with DRE. Results: The findings revealed several factors significantly influencing QoL in children with DRE. Comorbidities (OR = 24.98, p = 0.004, 95% CI) and high IL-1β levels (OR = 8.36, p = 0.022, 95% CI) were strongly correlated and significant factors in determining QoL, indicating 24.98- and 8.36-times higher likelihood of decreased QoL, respectively. Vitamin D levels had no statistically significant effect on QoL. Conclusion: Vitamin D levels have no substantial impact on QoL in children with DRE. IL-1β levels and comorbidities are crucial components affecting QoL in these patients. These findings highlight the importance of considering these factors in the management of children with DRE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.